TruBridge, Inc.

  • Market Cap: Micro Cap
  • Industry: Healthcare Services
  • ISIN: US2053061030
USD
23.59
0.7 (3.06%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About TruBridge, Inc. stock-summary
stock-summary
TruBridge, Inc.
Healthcare Services
Computer Programs and Systems, Inc. (CPSI) is a provider of healthcare information technology (IT) solutions for rural and community hospitals, and post-acute care facilities. The Company's segments include acute care EHR, post-acute care EHR, and TruBridge, Rycan, and other outsourcing. Its Acute Care EHR segment consists of acute care software solutions and supports sales generated by its subsidiaries, Evident, LLC (Evident) and Healthland Inc. (Healthland). Its Post-acute Care EHR segment consists of post-acute care software solutions and support sales generated by American HealthTech, Inc. (AHT). Its TruBridge, Rycan, and Other Outsourcing segment primarily consists of business management, consulting and managed IT services sales generated by TruBridge, LLC (TruBridge) and the sale of Rycan Technologies, Inc.'s (Rycan's) revenue cycle management workflow and automation software.
Company Coordinates stock-summary
Company Details
6600 Wall St , MOBILE AL : 36695-4512
stock-summary
Tel: 1 251 6398100
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 52 Schemes (45.4%)

Foreign Institutions

Held by 70 Foreign Institutions (9.92%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Glenn Tobin
Independent Chairperson of the Board
Mr. John Boyd Douglas
President, Chief Executive Officer, Director
Mr. David Dye
Director, Chief Growth Officer
Dr. Regina Benjamin
Independent Director
Mr. Christopher Hjelm
Independent Director
Mr. Charles Huffman
Independent Director
Mr. W. Austin Mulherin
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
86 Million
(Quarterly Results - Jun 2025)
Net Profit:
2 Million
stock-summary
Industry

Healthcare Services

stock-summary
Market cap

USD 301 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.89

stock-summary
Return on Equity

-2.57%

stock-summary
Price to Book

1.74